Clinical trial
Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation
NCT00452205 · Komagome Hospital, Other · Unknown status
Key facts
| NCT number | NCT00452205 |
|---|---|
| Title | Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation |
| Official title | Bone Marrow-derived Cells' Contribution to Tumor Formation and Epithelial Cells Regeneration in the Gastrointestinal Tract |
| Lead sponsor | Komagome Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Gastrointestinal Neoplasms |
| Enrollment | 300 |
| Start date | Apr 1, 2007 |
| Completion | Mar 1, 2017 |
| First posted | Mar 27, 2007 |
| Last update posted | Aug 4, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: